Cleveland Clinic Study Compares Weight Loss Strategies After GLP-1 Treatment
A Cleveland Clinic study presented at ObesityWeek analyzed five weight management strategies for 20,486 adults after stopping GLP-1 medications.

Surgery Yields Greatest Weight Loss
Those individuals receiving bariatric surgery shed an average of 28.2 percent of their body weight within a two-year period. This group shed approximately 31.5 kilograms compared to those who discontinued treatment entirely. People stopping GLP-1 medications regained weight with an average loss of only 4 percent during the same period.
Switching Medications Shows Moderate Results
Those switching between semaglutide and tirzepatide lost 16 percent of their body weight after two years. Continuing initial medication resulted in an average loss of 10.9 percent while switching to another drug yielded 8.2 percent. Participants with type 2 diabetes saw HbA1c reductions of 1.43 percent after switching medications versus 1.32 percent for continuation.
Experts Recommend Long Term Plans
Mir Ali MD stated that surgery remains the most durable intervention for severe obesity cases. He stated that taking GLP-1 prior to the procedure can safely decrease liver size and reduce surgical risk. Before stopping therapy, specialists advise collaborating with a medical expert to create a sustainable strategy for managing weight over time.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.